Northern Trust’s Apexigen, Inc. Common Stock APGN Stock Holding History

Northern Trust’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,041	Closed	-$13.3K	–	4571
2023 Q2	$13.3K	Hold	31,041	–	–	﹤0.01%	4458
2023 Q1	$15.1K	Hold	31,041	–	–	﹤0.01%	4486
2022 Q4	$21.2K	Hold	31,041	–	–	﹤0.01%	4477
2022 Q3	$84K	Buy	+31,041	New	+$253K	﹤0.01%	4172

Northern Trust's APGN Position: Q3 2023 in Review

Northern Trust sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 31,041 shares — an estimated $13.3K sold.

Northern Trust first reported a position in APGN in Q3 2022 and held it in 4 quarters. The position peaked at $84K in Q3 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

Northern Trust reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Northern Trust sold 31,041 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $13.3K.
Northern Trust first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Northern Trust's Apexigen, Inc. Common Stock position peaked at $84K in Q3 2022.
0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.